Trends and inequalities in statin use for the primary and secondary prevention of cardiovascular disease between 2009 and 2021 in England
Rutendo Muzambi, Krishnan Bhaskaran, Helen Strongman, Tjeerd van Staa, Liam Smeeth, Emily Herrett
doi: https://doi.org/10.1101/2024.11.22.24317782
Rutendo Muzambi
aFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
bFaculty of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, W12 0BZ, UK
Krishnan Bhaskaran
aFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
Helen Strongman
aFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
Tjeerd van Staa
cCentre for Health Informatics, Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, School of Health Sciences, The University of Manchester, Manchester Academic Health Science Centre, Vaughan House, Manchester, M13 9PL, UK
Liam Smeeth
bFaculty of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, W12 0BZ, UK
Emily Herrett
aFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
Data Availability
Data were obtained from the CPRD and are not publicly available. Access to CPRD data is dependent upon approval of a study protocol via CPRD RDG process (details at https://cprd.com/research-applications)
Posted November 23, 2024.
Trends and inequalities in statin use for the primary and secondary prevention of cardiovascular disease between 2009 and 2021 in England
Rutendo Muzambi, Krishnan Bhaskaran, Helen Strongman, Tjeerd van Staa, Liam Smeeth, Emily Herrett
medRxiv 2024.11.22.24317782; doi: https://doi.org/10.1101/2024.11.22.24317782
Trends and inequalities in statin use for the primary and secondary prevention of cardiovascular disease between 2009 and 2021 in England
Rutendo Muzambi, Krishnan Bhaskaran, Helen Strongman, Tjeerd van Staa, Liam Smeeth, Emily Herrett
medRxiv 2024.11.22.24317782; doi: https://doi.org/10.1101/2024.11.22.24317782
Subject Area
Subject Areas
- Addiction Medicine (395)
- Allergy and Immunology (708)
- Anesthesia (199)
- Cardiovascular Medicine (2907)
- Dermatology (249)
- Emergency Medicine (436)
- Epidemiology (12676)
- Forensic Medicine (10)
- Gastroenterology (823)
- Genetic and Genomic Medicine (4532)
- Geriatric Medicine (412)
- Health Economics (723)
- Health Informatics (2895)
- Health Policy (1066)
- Hematology (382)
- HIV/AIDS (918)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4297)
- Nursing (233)
- Nutrition (631)
- Oncology (2249)
- Ophthalmology (639)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (275)
- Palliative Medicine (83)
- Pathology (493)
- Pediatrics (1192)
- Primary Care Research (491)
- Public and Global Health (6879)
- Radiology and Imaging (1515)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (481)
- Toxicology (60)
- Transplantation (208)
- Urology (178)